Cannabis and the general practitioner - 'Going to pot'

British Journal of General Practice

Volumn 53, Issue 493, 2003, Pages 598-599

  Gerada, Clare ^a  

^a Hurley Clinic   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANNABIS; DIAMORPHINE; TAR;

ACCIDENT PRONENESS; ADVERTIZING; ANOREXIA; ANXIETY; ASTHMA; CANNABIS ADDICTION; CHRONIC BRONCHITIS; CLINICAL TRIAL; COGNITIVE DEFECT; CONCENTRATION LOSS; DEPRESSION; DISEASE EXACERBATION; DRUG DEPENDENCE; DRUG EFFECT; DRUG FATALITY; DRUG INFORMATION; DRUG MISUSE; EDITORIAL; GENERAL PRACTICE; GENERAL PRACTITIONER; GLAUCOMA; HEALTH HAZARD; HIGH RISK PATIENT; HUMAN; LOW BIRTH WEIGHT; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MEMORY DISORDER; MENTAL DISEASE; MUSCLE SPASM; NAUSEA AND VOMITING; PANIC; PHYSICIAN ATTITUDE; PSYCHOMOTOR DISORDER; PSYCHOSIS; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SIDE EFFECT; SMOKING; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; BRONCHITIS; HUMANS; MARIJUANA ABUSE; MENTAL DISORDERS; NEOPLASMS; PATIENT EDUCATION; PHYSICIAN'S ROLE;

EID: 0043244879     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (21)

1. World Health Organisation. Programme on Substance Abuse. Cannabis: A Health Perspective and Research Agenda. Geneva: WHO, 1997.
2. Maykut MO. Health consequences of acute and chronic marihuana use. Prog Neuropsychopharmacol Biol Psychiatry 1985; 9: 209-238.
3. Lishman W.A. Organic Psychiatry: The Psychological Consequences of Cerebral Disorder. Third Edition. Oxford: Blackwell Science, 1998.
4. Gold MS. Marijuana. In: Comprehensive Handbook of Alcohol and Drug Addiction. New York: Marcel Dekker Inc, 1991; 353-376.
5. Swift W, Hall W, Tesson M. Cannabis use and dependence among young Australian adults: Results from the National Survey of Mental State and Wellbeing. Addiction 2001; 96: 737-748.
6. Chait LD, Pierri J. Effects of smoked marijuana on human performance: A critical review. In: Murphy L, Bartke A (eds). Marijuana/Cannabinoids: Neurobiology and Neurophysiology. Boca Raton: CRC Press, 1992; 387-424.
7. Ashthon CH. Adverse effects of cannabis and cannabinoids. Br J Anaesth 1999; 83: 637-649.
8. Patton G, Coffey C. Cannabis use and mental health in young people: Cohort study. BMJ 2002: 325: 1195-1198.
9. Zammit S, Allebeck P, Andreasson S, et al. Self-reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. BMJ 2002; 325: 1199-1201.
10. British Lung Foundation. A Smoking Gun? The Impact of Cannabis Smoking on Respiratory Health. London: BLF, 2002.
11. Tramèr MR, Carroll D, Campbell FA, et al. Cannabinoids for the control of chemotherapy-induced nausea and vomiting: A systematic review. BMJ 2001; 323(7303): 16-21.
12. Tramèr MR, Carroll D, Campbell F, et al. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001; 323(7303): 13-16.
13. Cannabis trial launched in patients with MS. [News item.] BMJ 2001; 322(7280): 192.
14. Robson P. Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry 2001; 178: 107-115.
15. Runciman R. Drugs and the Law. Report of the Independent Inquiry into the Misuse of Drugs Act 1971. London: The Police Foundation, 2000.
16. Select Committee on Home Affairs. The Work of the Home Affairs Committee in 2002. Third Report. London: The Stationery Office, 2003.
17. House of Lords Select Committee on Science and Technology. Cannabis: The Scientific and Medical Evidence. London: The Stationery Office, 1988.
18. Mahaney F. Old-time ads tout health benefits of smoking: Tobacco industry had doctors' help. [News item.] J Natl Cancer Inst 1994; 86: 14.
19. Action on Smoking and Health (ASH). URL: http://www.ash.org.uk accessed 31 March 2003
20. Miller P, Plant M. Heavy cannabis use among UK teenagers: An exploration. Drug Alcohol Depend 2002; 65: 235-242.
21. Hall W, Solowij N, Lemon J (eds). The Health and Psychological Consequences of Cannabis Use. National Drug Strategy Monograph Series Number 25. Canberra: Australian Government Publishing Service, 1994.